High Tech Pharm Co. Ltd (106190) — Cash Flow-to-Debt Ratio
High Tech Pharm Co. Ltd (106190) has a Cash Flow-to-Debt Ratio of 0.52x as of September 2025, meaning its operating cash flow of ₩6.60 Billion could theoretically repay 1% of its total liabilities (₩12.57 Billion) in one year. Explore High Tech Pharm Co. Ltd strategic investment ratio to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
High Tech Pharm Co. Ltd Cash Flow-to-Debt Ratio (2014–2024)
Historical debt coverage capacity for High Tech Pharm Co. Ltd across 11 annual periods. Also explore total assets of High Tech Pharm Co. Ltd for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for High Tech Pharm Co. Ltd (2014–2024)
Year-by-year debt coverage analysis for High Tech Pharm Co. Ltd. For market capitalisation and broader financial context, see market cap of High Tech Pharm Co. Ltd.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.72x | ₩14.69 Billion | ₩20.35 Billion | ▲ +596.5% |
| 2023 | 0.10x | ₩2.91 Billion | ₩28.06 Billion | ▲ +190.3% |
| 2022 | -0.11x | ₩-3.70 Billion | ₩32.26 Billion | ▼ -148.1% |
| 2021 | 0.24x | ₩6.93 Billion | ₩29.05 Billion | ▲ +203.3% |
| 2020 | -0.23x | ₩-7.69 Billion | ₩33.30 Billion | ▼ -408.1% |
| 2019 | 0.07x | ₩2.48 Billion | ₩33.14 Billion | ▼ -58.7% |
| 2018 | 0.18x | ₩5.38 Billion | ₩29.65 Billion | ▼ -43.8% |
| 2017 | 0.32x | ₩5.45 Billion | ₩16.90 Billion | ▲ +281.7% |
| 2016 | 0.08x | ₩1.45 Billion | ₩17.13 Billion | ▼ -90.5% |
| 2015 | 0.89x | ₩12.71 Billion | ₩14.23 Billion | ▲ +27.6% |
| 2014 | 0.70x | ₩10.17 Billion | ₩14.53 Billion | — |